Showing results (501-510 of 521) with videos related to

Sort By:
Pageof 53
Vaccines|January 22, 2024
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, et al.
Neuroimage|February 15, 2021
Uncertainty analysis of MR-PET image registration for precision neuro-PET imagingPawel J Markiewicz, Julian C Matthews, John Ashburner, et al.
AIDS (London, England)|October 6, 2018
Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infectionLorna Leal, Alberto C Guardo, Sara Morón-López, et al.
ACS Nano|September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyKevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
American Journal of Hematology|August 19, 2015
Lenalidomide is safe and active in Waldenström macroglobulinemiaGuillemette Fouquet, Stéphanie Guidez, Marie-Odile Petillon, et al.
Neuroimage|May 23, 2021
Validation of a combined image derived input function and venous sampling approach for the quantification of [<sup>18</sup>F]GE-179 PET binding in the brainMarian Galovic, Kjell Erlandsson, Tim D Fryer, et al.
Human & Experimental Toxicology|March 1, 1996
Development and validation of new screening tests for nephrotoxic effectsR G Price, S A Taylor, I Chivers, et al.
NPJ Vaccines|March 6, 2024
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA ConsortiumLaura Marcos-Villar, Beatriz Perdiguero, Shubaash Anthiya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patientsErik H J G Aarntzen, Gerty Schreibelt, Kalijn Bol, et al.
The European Respiratory Journal|February 16, 2019
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisPauline T Lukey, Stephen A Harrison, Shuying Yang, et al.
Pageof 53